Novel PVA-based hydrogel microparticles for doxorubicin delivery

Area of Science:

• Polymer science and nanotechnology
• Drug delivery systems
• Cancer research

Background:

• Micro- and nanoparticles offer advantages for drug delivery due to their surface area and tunable properties.
• Polymer hydrogels are explored for encapsulating therapeutic agents.
• Developing effective drug carriers for cancer therapy remains a critical challenge.

Purpose of the Study:

• To develop and characterize chemically cross-linked polymer microparticles for drug delivery.
• To evaluate the doxorubicin loading capacity and in vitro release kinetics of these microparticles.
• To assess the cytotoxic effects of doxorubicin-loaded microparticles on LoVo colon cancer cells.

Main Methods:

• Polymer/polymer/water emulsion method for hydrogel microparticle synthesis.
• Laser scanning confocal microscopy for mesoscopic investigation.
• Quasi-elastic incoherent neutron scattering for studying water dynamics.
• Succinoylation for doxorubicin loading.
• In vitro cytotoxicity assays using LoVo colon cancer cells.

Main Results:

• Chemically cross-linked hydrogel microparticles were successfully produced from poly(vinyl alcohol) and poly(methacrylate).
• Succinoylation enabled efficient doxorubicin loading, achieving up to 50% (w/w) payload.
• In vitro studies demonstrated effective doxorubicin release and significant cytotoxic effects on colon cancer cells.

Conclusions:

• The developed polymer microparticles are promising candidates for doxorubicin delivery in cancer therapy.
• The microparticle system exhibits efficient drug loading and controlled release, leading to cancer cell death.
• Further investigation into in vivo applications of these microparticle drug delivery systems is warranted.